Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA

Nature Genetics

Volumn 20, Issue 2, 1998, Pages 198-202

  Hemachandra Reddy, P ^a   Williams, Maya ^a   Charles, Vinod ^a   Garrett, Lisa ^a   Pike Buchanan, Lisa ^a   Whetsell Jr , William O ^b   Miller, Georgina ^c   Tagle, Danilo A ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; GENE EXPRESSION; GENE TARGETING; GENETIC ANALYSIS; GLIOSIS; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; INVOLUNTARY MOVEMENT; MOTOR DYSFUNCTION; MOUSE; NERVE DEGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RESTLESSNESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TRANSGENIC MOUSE; TRINUCLEOTIDE REPEAT;

ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DNA, COMPLEMENTARY; HUMANS; HUNTINGTON DISEASE; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONS; NUCLEAR PROTEINS; RESTRICTION MAPPING; TRINUCLEOTIDE REPEATS; UBIQUITINS;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 17344367977     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/2510     Document Type: Article

References (30)

1. Vonsattel, J.P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559-577 (1985).
2. Folstein, S.E. Huntington's Disease (Johns Hopkins University Press, Baltimore, 1990).
3. Hedreen, J.C., Peyser, C.E., Folstein, S.E. & Ross, C.A. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 133, 257-261 (1991).
4. Spargo, E., Everall, I.P. & Lantos, P.L. Neuronal loss in the hippocampus in Huntington's disease: a comparison with HIV infection. J. Neurol. Neurosurg. Psychiatry 56, 487-491 (1993).
5. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983 (1993).
6. Andrew, S.E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398-403 (1993).
7. Duyao, M. et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nature Genet. 4, 387-392 (1993).
8. Stine, O.C. et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum. Mol. Genet. 2, 1547-1549 (1993).
9. Li, S.H. et al. Huntington's disease gene (IT15) is widely expressed in human and rat tissues. Neuron 11, 985-993 (1993).
10. Strong, T.V. et al. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nature Genet. 5, 259-265 (1993).
11. Sharp, A.H. et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14, 1065-1074 (1995).
12. Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506 (1996).
13. Ordway, J.M. et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 91, 753-764 (1997).
14. Wood, J.D., MacMillan, J.C., Harper, P.S., Lowenstein, P.R. & Jones, A.L. Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain. Hum. Mol. Genet. 5, 481-487 (1996).
15. White, J.K. et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nature Genet. 17, 404-410 (1997).
16. Franklin, K.B.J. & Paxinos, G. The Mouse Brain in Stereotaxic Coordinates (Academic Press, San Diego, 1997).
17. Dragunow, M. et al. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. Neuroreport 6, 1053-1057 (1995).
18. Portera-Cailliau, C., Hedreen, J.C, Price, D.L. & Koliatsos, K.E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787 (1995).
19. Thomas, L.B. et al. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133, 265-272 (1995).
20. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548 (1997).
21. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993 (1997).
22. Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333-344 (1997).
23. Skinner, P.J. et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974 (1997).
24. Borlongan, C.V., Koutouzis, T.K. & Sanberg, P.R. 3-Nitropropionic acid animal model and Huntington's disease. Neurosci. Biobehav. Rev. 21, 289-293 (1997).
25. Brinkman, R.R., Mezei, M.M., Theilmann, J., Almqvist, E. & Hayden, M.R. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum. Genet. 60, 1202-1210 (1997).
26. Kosinski, C.M. et al. Huntingtin immunoreactivity in the rat neostriatum: differential accumulation in projection and interneurons. Exp. Neurol. 144, 239-247 (1997).
27. Reddy, P.S. & Housman, D.E. The complex pathology of trinucleotide repeats. Curr. Opin. Cell Biol. 9, 364-372 (1997).
28. Matilla, A. et al. The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1. Nature 389, 974-978 (1997).
29. Jou, Y.S. & Myers, R.M. Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465-469 (1995).
30. Liu, Y.F., Deth, R.C. & Devys, D.E. SH3 domain-dependent association of huntingtin with epidermal growth factor receptor signaling complexes. J. Biol. Chem. 272, 8121-8124 (1997).